Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Part 1: When to test
PARP inhibition in the treatment of prostate cancer
Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 2: Who to test
PARP inhibition in the treatment of prostate cancer
Part 2: Who to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 3: How to test
PARP inhibition in the treatment of prostate cancer
Part 3: How to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 4: Metastatic prostate cancer and HRR defects
PARP inhibition in the treatment of prostate cancer
Part 4: Metastatic prostate cancer and HRR defects ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 5: BRCA 1/2 mutations and prostate cancer
PARP inhibition in the treatment of prostate cancer
Part 5: BRCA 1/2 mutations and prostate cancer ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
The role of testing in prostate cancer treatment
Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki
The role of testing in prostate cancer treatment ( Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki )
20 Jul 2021
Prostate cancer screening using prostate-specific antigen, a multiplex blood-tes...
Prof Martin Eklund - Karolinska Institutet, Solna, Sweden
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies ( Prof Martin Eklund - Karolinska Institutet, Solna, Sweden )
20 Jul 2021
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer ( Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy )
19 Jul 2021
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-...
Dr Michael Morris - Memorial Sloan Kettering Cancer Center and Weill Cornell Med...
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION) ( Dr Michael Morris - Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, USA )
15 Jul 2021
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600...
Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer ( Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain )
13 Jul 2021
Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in...
Dr Zev Wainberg - University of California Los Angeles, California, USA
Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic oesophageal cancer ( Dr Zev Wainberg - University of California Los Angeles, California, USA )
12 Jul 2021
FGFR as a tumour agnostic indicator and its importance in the diagnosis and trea...
Dr Christophe Massard and Prof Eva Compérat
FGFR as a tumour agnostic indicator and its importance in the diagnosis and treatment of multiple solid tumour types ( Dr Christophe Massard and Prof Eva Compérat )
1 Jul 2021